Effects of Urate-Lowering Therapy on Risk of Hyperlipidemia in Gout by a Population-Based Cohort Study and on In Vitro Hepatic Lipogenesis-Related Gene Expression
Patients with gout are at a higher risk of cardiovascular disease, which is associated with hyperlipidemia. Management of gout in Taiwan is poor, and the association between urate-lowering therapy (ULT) among gout patients and hyperlipidemia is unclear. We conducted a retrospective cohort study usin...
Main Authors: | Yi-Jen Fang, Tien-Yuan Wu, Cheng-Li Lin, Chih-Yang Su, Jia-Rong Li, Yun-Lung Chung, Ni Tien, Yun-Ping Lim |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2020/8890300 |
Similar Items
-
Association between Gout, Urate-Lowering Therapy, and Risk of Developing Type 2 Diabetes Mellitus: A Nationwide Population-Based Retrospective Cohort Study
by: Yi-Jen Fang, et al.
Published: (2020-01-01) -
Variation in serum urate levels in the absence of gout and urate lowering therapy
by: Andrew Shaffer, et al.
Published: (2021-09-01) -
Impact of diuretics on the urate lowering therapy in patients with gout: analysis of an inception cohort
by: Laura Ranieri, et al.
Published: (2018-03-01) -
A Population-Based Cohort Study on the Association of Hyperthyroidism With the Risk of Hyperlipidemia and the Effects of Anti-thyroid Drugs on Hepatic Gene Expression
by: Tien-Yuan Wu, et al.
Published: (2020-05-01) -
Treatment approaches and adherence to urate-lowering therapy for patients with gout
by: Aung T, et al.
Published: (2017-04-01)